Science Applications International Corporation · NASDAQ:SAIC
Science Applications International — Q2 2021 Earnings Presentation
13 slides from Science Applications International's earnings presentation, Sep 2, 2020
Slide 1: Fiscal Year 2021 Second Quarter Earnings Call
Science Applications International Corporation (SAIC) Fiscal Year 2021 Second Quarter Earnings Call Supplemental Financial Information September 2, 2020
Slide 2: Forward Looking Statement
Forward Looking Statement Certain statements in this presentation are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “should,” “expects,” “intends,” “projects,” “plans,” “believes,” “estimates,” “targets,” “antici
Slide 3: Today's Presenters
Today’s Presenters Nazzic S. Keene Charles A. Mathis Chief Executive Officer Chief Financial Officer 3 © SAIC. All rights reserved. S A I C P R O P R I E T A R Y
Slide 4: FY2021 Q2 Highlights
FY2021 Q2 Highlights Modest Impact from COVID-19, Resilient Business and Market Continued Strategy Execution, Minor Portfolio Shaping Q2 Total Revenue Growth of 11% (1% Internal Contraction, 3% Internal Growth After Adjusting for COVID-19 Impact) * Q2 Adjusted EBITDA Margin of 9.5%, 10 bps Negative
Slide 5: SAIC Second Quarter FY2021 Results
(1) SAIC Second Quarter FY2021 Results ADJUSTED ADJUSTED REVENUE FREE CASH FLOW(2) EBITDA MARGIN(2)(3) DILUTED EPS (2)(3) +11% +110 bps 9.5% +21% $1,764M $90M $90M 8.4% $1.63 $1,594M $1.35 FY2020 FY2021 FY2020 FY2021 FY2020 FY2021 FY2020 FY2021 Q2 Q2 Q2 Q2 Q2 Q2 Q2 Q2 (1) Results of Science Applicat
Slide 6: SAIC Year-to-Date FY2021 Results
(1) SAIC Year-to-Date FY2021 Results ADJUSTED ADJUSTED REVENUE FREE CASH FLOW(2)(3) EBITDA MARGIN(2)(4) DILUTED EPS (2)(4) -4% +10% +20 bps +10% $259M $3,521M $248M 8.6% 8.4% $2.99 $3,209M $2.71 FY2020 FY2021 FY2020 FY2021 FY2020 FY2021 FY2020 FY2021 Q2 Q2 Q2 Q2 Q2 Q2 Q2 Q2 (1) Results of Science Ap
Slide 7: Fiscal Year 2021 Guidance
Fiscal Year 2021 Guidance Current Prior 10.5 months of Unisys Federal Revenue $7.1B - $7.2B $7.1B - $7.3B ~$250M of unfavorable impact due to COVID-19 Guided range reflects 1% - 3% organic growth * Adjusted Diluted EPS $5.80 - $6.10 $5.80 - $6.10 ~$35M unfavorable pre-tax impact due to COVID
Slide 8: Appendix
Appendix
Slide 9: Working Days Per Quarter
Working Days Per Quarter Q1 Q2 Q3 Q4 Total FY21 64 63 63 60 250 FY20 64 63 63 60 250 FY19 64 63 63 60 250 FY18 64 63 64 59 250 9 © SAIC. All rights reserved. S A I C P R O P R I E T A R Y
Slide 10: Pay Periods Per Quarter
Pay Periods Per Quarter Q1 Q2 Q3 Q4 Total FY21 6 7 6 7 26 FY20 6 7 6.5* 7 26 FY19 6 7 6 7 26 FY18 6 7 6 7 26 *During the third quarter of fiscal year 2020 and as a result of a systems conversion due to the Engility acquisition, legacy Engility employees were paid a one week payroll cycle in order to
Slide 11: Non-GAAP Reconciliation - EBITDA and Adjusted EBITDA
Non-GAAP Reconciliation - EBITDA and Adjusted EBITDA (1) “EBITDA“ and “Adjusted EBITDA” are non-GAAP financial measures that are reconciled in this schedule to the most directly comparable GAAP financial measures. These non-GAAP financial measures help investors better understand profitability trend
Slide 12: Non-GAAP Reconciliation - Adjusted Diluted Earnings per Share
Non-GAAP Reconciliation - Adjusted Diluted Earnings per Share (1) “Adjusted diluted earnings per share” is a non-GAAP financial measure that is reconciled in this schedule to the most directly comparable GAAP financial measures. This non-GAAP financial measure provides investors with greater visibil
Slide 13: Non-GAAP Reconciliation - Free Cash Flow
Non-GAAP Reconciliation - Free Cash Flow (1) “Free cash flow” is a non-GAAP financial measure that is reconciled in this schedule to the most directly comparable GAAP financial measures. This non-GAAP financial measure provides investors with greater visibility into cash flows provided by operating
Science Applications International — Q2 2021 Earnings Presentation on 6ix